Browsing Tag
First Tracks Biotherapeutics
2 posts
First Tracks Biotherapeutics delivers major ANB033 trial win as celiac drug competition intensifies
First Tracks Biotherapeutics stock jumps on positive ANB033 celiac disease trial data. Discover what the results mean for investors and its growth outlook.
October 14, 2026
Why AnaptysBio’s new CFO hire may matter more than a routine biotech appointment
AnaptysBio is no longer a classic biotech pipeline bet. Christopher Murphy’s CFO appointment tests whether ANAB can execute as a royalty vehicle.
May 11, 2026